AAAAAA
Results:
1-21
|
Results: 21
Authors:
Hruban, RH
Iacobuzio-Donahue, C
Wilentz, RE
Goggins, M
Kern, SE
Citation: Rh. Hruban et al., Molecular pathology of pancreatic cancer, CANCER J, 7(4), 2001, pp. 251-258
Authors:
Tascilar, M
Offerhaus, GJA
Altink, R
Argani, P
Sohn, TA
Yeo, CJ
Cameron, JL
Goggins, M
Hruban, RH
Wilentz, RE
Citation: M. Tascilar et al., Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct, AM J CLIN P, 116(6), 2001, pp. 831-837
Authors:
Tersmette, AC
Petersen, GM
Offerhaus, GJA
Falatko, FC
Brune, KA
Goggins, M
Rozenblum, E
Wilentz, RE
Yeo, CJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: Ac. Tersmette et al., Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer, CLIN CANC R, 7(3), 2001, pp. 738-744
Authors:
Geradts, J
Wilentz, RE
Roberts, H
Citation: J. Geradts et al., Utimmunohistochemical detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: Correlation with p16(INK4a) expression, MOD PATHOL, 14(11), 2001, pp. 1162-1168
Authors:
McCarthy, DM
Brat, DJ
Wilentz, RE
Yeo, CJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: Dm. Mccarthy et al., Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: Analysis of progression and recurrence by DPC4 immunohistochemical labeling, HUMAN PATH, 32(6), 2001, pp. 638-642
Authors:
Maurice, D
Pierreux, CE
Howell, M
Wilentz, RE
Owen, MJ
Hill, CS
Citation: D. Maurice et al., Loss of Smad4 function in pancreatic tumors - C-terminal truncation leads to decreased stability, J BIOL CHEM, 276(46), 2001, pp. 43175-43181
Authors:
Argani, P
Rosty, C
Reiter, RE
Wilentz, RE
Murugesan, SR
Leach, SD
Ryu, BW
Skinner, HG
Goggins, M
Jaffee, EM
Yeo, CJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: P. Argani et al., Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma, CANCER RES, 61(11), 2001, pp. 4320-4324
Authors:
Argani, P
Shaukat, A
Kaushal, M
Wilentz, RE
Su, GH
Sohn, TA
Yeo, GJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: P. Argani et al., Differing rates of loss of Dpc4 expression and of p53 overexpression amongcarcinomas of the proximal and distal bile ducts - Evidence for biologic distinction, CANCER, 91(7), 2001, pp. 1332-1341
Authors:
Wilentz, RE
Argani, P
Hruban, RH
Citation: Re. Wilentz et al., Loss of heterozygosity or intragenic mutation, which comes first?, AM J PATH, 158(5), 2001, pp. 1561-1563
Authors:
Montgomery, E
Goggins, M
Zhou, SB
Argani, P
Wilentz, RE
Kaushal, M
Booker, S
Romans, K
Bhargava, P
Hruban, RH
Kern, SE
Citation: E. Montgomery et al., Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects, AM J PATH, 158(2), 2001, pp. 537-542
Authors:
Wilentz, RE
Witters, LA
Pizer, ES
Citation: Re. Wilentz et al., Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues, PEDIATR D P, 3(6), 2000, pp. 525-531
Authors:
Wilentz, RE
Albores-Saavedra, J
Hruban, RH
Citation: Re. Wilentz et al., Mucinous cystic neoplasms of the pancreas, SEM DIAGN P, 17(1), 2000, pp. 31-42
Authors:
Iacobuzio-Donahue, CA
Wilentz, RE
Argani, P
Yeo, CJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: Ca. Iacobuzio-donahue et al., Dpc4 protein in mucinous cystic neoplasms of the pancreas - Frequent loss of expression in invasive carcinomas suggests a role in genetic progression, AM J SURG P, 24(11), 2000, pp. 1544-1548
Authors:
Wilentz, RE
Iacobuzio-Donahue, CA
Argani, P
McCarthy, DM
Parsons, JL
Yeo, CJ
Kern, SE
Hruban, RH
Citation: Re. Wilentz et al., Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression, CANCER RES, 60(7), 2000, pp. 2002-2006
Authors:
Iacobuzio-Donahue, CA
Klimstra, DS
Adsay, NV
Wilentz, RE
Argani, P
Sohn, TA
Yeo, CJ
Cameron, JL
Kern, SE
Hruban, RH
Citation: Ca. Iacobuzio-donahue et al., Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas - Comparison with conventional ductal adenocarcinomas, AM J PATH, 157(3), 2000, pp. 755-761
Authors:
Hruban, RH
Wilentz, RE
Kern, SE
Citation: Rh. Hruban et al., Genetic progression in the pancreatic ducts - Commentary, AM J PATH, 156(6), 2000, pp. 1821-1825
Authors:
Wilentz, RE
Goggins, M
Redston, M
Marcus, VA
Adsay, NV
Sohn, TA
Kadkol, SS
Yeo, CJ
Choti, M
Zahurak, M
Johnson, K
Tascilar, M
Offerhaus, GJA
Hruban, RH
Kern, SE
Citation: Re. Wilentz et al., Genetic, immunohistochemical, and clinical features of medullary carcinomaof the pancreas - A newly described and characterized entity, AM J PATH, 156(5), 2000, pp. 1641-1651
Authors:
Wilentz, RE
Su, GH
Le Dai, J
Sparks, AB
Argani, P
Sohn, TA
Yeo, CJ
Kern, SE
Hruban, RH
Citation: Re. Wilentz et al., Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreaticadenocarcinomas - A new marker of DPC4 inactivation, AM J PATH, 156(1), 2000, pp. 37-43
Authors:
Hruban, RH
Wilentz, RE
Goggins, M
Offerhaus, GJA
Yeo, CJ
Kern, SE
Citation: Rh. Hruban et al., Pathology of incipient pancreatic cancer, ANN ONCOL, 10, 1999, pp. 9-11
Authors:
Le Dai, J
Schutte, M
Bansal, RK
Wilentz, RE
Sugar, AY
Kern, SE
Citation: J. Le Dai et al., Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells, MOL CARCINO, 26(1), 1999, pp. 37-43
Authors:
Wilentz, RE
Albores-Saavedra, J
Zahurak, M
Talamini, MA
Yeo, CJ
Cameron, JL
Hruban, RH
Citation: Re. Wilentz et al., Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas, AM J SURG P, 23(11), 1999, pp. 1320-1327
Risultati:
1-21
|